Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Revista ANACEM ; 16(2):207-207, 2022.
Article in Spanish | Academic Search Complete | ID: covidwho-2170029

ABSTRACT

Introduction: Peritonitis reaches an overall mortality up to 60%. Given the lack of national epidemiological studies, it is proposed the calculation of the mortality rate (MR) due to peritonitis between the years 2017-2021 in Chile. Methodology: Descriptive, ecological study about deaths by peritonitis between 2017 and 2021 in Chile (N=1,741), in a population older than 15 years old according to age group, sex and region with data obtained from Departamento de Estadística e Información en Salud. Descriptive statistics were used, MR calculation and Swaroop Index (SI). It did not require approval by an ethics committee. Results: A MR of 2.47/100.000 was calculated between the years 2017 and 2021, with 2020 being the highest with 3.07. The female sex presented a rate of 2.65. The age group with the highest MR is 80 and over with 141.7/100.000. For the SI by region, the XV and XII regions lead with 100%, the lowest being XI region with 83.3%. Discussion:: The peak of MR for the year 2020 coincides with the Covid-19 pandemic and the highest postoperative mortality on infected patients. The SI remains above 90% in the country, except in X and XI regions, probably due to the lower availability of high complexity centers. Conclusion: Given the lack of recent mortality data for peritonitis, a local epidemiological update was carried out, with a regional comparative perspective regarding MR in the general population and in those over 50 years old. (English) [ FROM AUTHOR]

2.
Harm Reduct J ; 19(1): 139, 2022 Dec 12.
Article in English | MEDLINE | ID: covidwho-2162375

ABSTRACT

BACKGROUND: Female sex workers (FSW) have been disproportionately impacted by the Covid-19 crisis. Data show increases of police violence toward key populations (KP), likely a consequence of their role in enforcing health government measures. This study aimed to identify factors associated with police violence experienced by FSW during the Covid-19 crisis in Argentina. METHODS: EPIC is a multi-country, cross-sectional, community-based research program evaluating the impact of Covid-19 among KP. In Argentina, the study was conducted in collaboration with FSW community-based organizations (CBO). Participants completed an online survey (October 2020-April 2021). Police violence was measured as having experienced episodes of violence (physical, verbal, psychological or sexual) by security forces since the start of the health crisis. Factors associated with police violence were assessed in logistic regression models. RESULTS: Among 173 respondents, median age was 34 [IQR 27-42], 39.3% were transgender women (TW), 78.1% declared sex work as their only income and 71.7% mentioned their financial situation has deteriorated with the health crisis. Nearly half of FSW (44.5%) reported experiencing police violence within the first year of the Covid-19 pandemic, and among them, 76.6% declared more frequent violence episodes since the beginning of the health crisis. After adjustment for age, being a TW (aOR [95% CI] = 2.71 [1.21;6.05]), reporting non-injection drug use (2.92 [1.02;8.36]), having a considerably deteriorated financial situation (3.67 [1.47;9.21]), having had a consultation with a CBO worker for medical care/treatments (5.56 [2.15;14.37]) and declaring fear or experiences of discrimination by physicians/other health workers (2.97 [1.21;7.29]), since the beginning of the Covid-19 health crisis, were independently associated with police violence. CONCLUSIONS: FSW in Argentina have experienced an increase in police violence since the beginning of the health crisis. Belonging to multiple KP (FSW, TW, people who use drugs) increases the likelihood of experiencing police violence, highlighting the need of an intersectional approach to develop interventions to reduce stigma and violence against FSW. CBOs have provided essential support and services during the crisis to FSWs, and other KPs, who may have avoided traditional healthcare structures due to fear or experiences of discrimination.


Subject(s)
COVID-19 , HIV Infections , Sex Workers , Female , Humans , Adult , Cross-Sectional Studies , Pandemics , HIV Infections/epidemiology
3.
Annals of the Rheumatic Diseases ; 81:1691-1692, 2022.
Article in English | EMBASE | ID: covidwho-2009082

ABSTRACT

Background: In the current situation of the SARS-CoV-2 pandemic, the Spanish Society of Rheumatology recommends vaccination of patients with chronic infammatory diseases (CID) under treatment with biological DMARDs (bDMARDs). However, the data regarding the generation of protective antibody titers after mRNA vaccines in patients with CID is limited. Objectives: To determine the seroconversion rate and safety after the SARS-CoV-2 vaccine in patients with CID under treatment with bDMARDs Methods: Cross-sectional observational study of 81 patients with CID from the HURS in Córdoba, who have received full vaccination for SARS-CoV-2 (without having previously suffered from COVID-19 disease) according to national guidelines. A determination of specifc IgG-type antibodies against the trimeric spike protein of SARS-CoV2 was performed on all of them. The chemilumines-cence technique with the kit was used in serum samples taken 4-5 weeks after administration of the second dose of the vaccine. Information about sociode-mographic characteristics, disease, type of bDMARDs, concomitant treatments and adverse effects after the second dose of the vaccine were collected in each patient. Results: 81 patients were included (mean age 59.5, 72.8% females). 50.6% of patients had RA, 17.3% SpA, 11% PsoA and 18.5% other CID. 23.5% were under treatment with Rituximab, 38.8% antiTNF, 13.6% Tocilizumab, 9.9% abatacept, 5% anti-JAK and 14.2% under other treatments. Anti-SARS-CoV-2 antibodies and neutralizing activity were detected in 80% of study participants. Rituximab treatment was signifcantly associated with negative seroconver-sion in comparison with patients under antiTNF treatment (OR 84.0 (95%CI 12.9-1709.2)). No interaction was found between the bDMARDs treatment and the type of vaccine with regard to the seroconversion, nor between bDMARDs and concomitant synthetic DMARD. When we evaluated IgG titers against the spike protein of SARS-CoV2, we found that patients under treatment with Rituximab showed the lowest titers levels in comparison with patients with other treatments (Figure 1, Table 1). In addition, patients who received AstraZeneca vaccine developed lower titers of antibodies in comparison with patients who received Pfzer (Table 1). Interestingly, among patients with antiTNF treatment, AstraZeneca was associated with lower IgG titers in comparison with Pfzer and Moderna [405.9 (553.0) vs. 1084.1 (791.2) vs. 1264.0 (1012.6), p=0.016, respectively]. No differences between vaccines were found in patients with the other type of bDMARDs. Only 18.9% presented mild adverse effects. No serious adverse effects were observed and no patient experienced a disease fare after vaccination. Conclusion: Our results show that SARS-CoV-2 mRNA vaccines produce sero-conversion in most patients with CID, except in the case of patients with rituxi-mab. No severe adverse effects or CID reactivation were found. Despite the small number of patients included, this study suggests the need for revaccination in the group of patients treated with rituximab or vaccinated with Astrazeneca.

4.
Revista del Hospital Psiquiatrico de la Habana ; 17(3), 2020.
Article in English, Spanish | Scopus | ID: covidwho-1981162

ABSTRACT

Introduction: Generalized anxiety disorder has increased its frequency in our city since the onset of the Covid-19 pandemic. There are a small number of patients who do not wish to be treated pharmacologically Objective: Comment on the efficacy of mindfulness-enriched cognitive behavioral treatment in a woman with generalized anxiety disorder and insomnia who did not want to receive pharmacological management Presentation of the case: A 60-year-old woman, with a history of anxiety, did not wish to receive drug therapy and requested psychological support due to fatigue, frequent headaches, palpitations, irritable bowel, memory problems, poor concentration and insomnia. A diagnosis of generalized anxiety disorder was made and the psychological assessment was made with the following instruments: inventory of automatic thoughts by Ruiz and Lujan, the Oviedo del Sueño questionnaire and the IDARE anxiety scale before and after a cognitive-behavioral intervention enriched with mindfulness. Conclusions: The level of state anxiety decreased from high to moderate and that of trait anxiety from high to mild, sleep problems went from high to medium level, and the frequency of cognitive distortions decreased. The intervention made it possible to identify and treat cognitive distortions, modify poor sleep hygiene habits, and promoted the acquisition of problem-solving skills. © 2020. All Rights Reserved.

SELECTION OF CITATIONS
SEARCH DETAIL